Skip to content

Evaluation of the CARE intervention for newly diagnosed pulmonary tuberculosis patients

Evaluation of the CARE intervention for newly diagnosed pulmonary tuberculosis patients

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500113744
Enrollment
Unknown
Registered
2025-12-02
Start date
2025-12-12
Completion date
Unknown
Last updated
2026-01-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Tuberculosis

Interventions

Intervention Group:Provision of a CARE-based comprehensive intervention, including follow-up management, health education, and nutritional support.
Control group:Adopting standard tuberculosis management

Sponsors

Nanjing Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Patients with active, newly diagnosed pulmonary tuberculosis confirmed by pathogen testing and imaging; 2. Age 18-65 years;

Exclusion criteria

Exclusion criteria: 1.Individuals with a confirmed diagnosis of severe hepatic insufficiency or decompensated cirrhosis, or those with confirmed end-stage renal disease or requiring dialysis; and any patients whom clinicians judge, due to hepatic or renal dysfunction, to be unable to receive standard first-line anti-tuberculosis therapy according to national guidelines; 2.Patients with previously treated (retreatment) pulmonary tuberculosis; 3.Individuals with severe communication barriers (including psychiatric, visual, auditory, or speech impairments); 4.Pregnant or lactating women; 5.Patients diagnosed with malignant neoplasms; 6. Individuals with known allergies to any component of the nutritional supplement package.

Design outcomes

Primary

MeasureTime frame
Treatment adherence rate;Treatment success rate;

Secondary

MeasureTime frame
2-week sputum conversion rate.;Quality of life;

Countries

China

Contacts

Public ContactJianming Wang

School of Public Health, Nanjing Medical University

jmwang@njmu.edu.cn+86 159 9649 6360

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026